Clinical Trial Update: Efficacy and Safety of Hyperbaric Oxygen Therapy in Improving Nab-paclitaxel-Induced Peripheral Neuropathy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating hyperbaric oxygen therapy to improve nab-paclitaxel-induced peripheral neuropathy in breast cancer patients; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chemotherapy-induced Peripheral Neuropathy
• Paclitaxel-induced Peripheral Neuropathy

Drugs mentioned

• Hyperbaric Oxygen Therapy

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Breast Cancer, CIPN - Chemotherapy-Induced Peripheral Neuropathy | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING